Farletuzumab ELISA Kit

SKU:BHE21400316
Overview
Click light‑blue chips for details
Farletuzumab ELISA Kit is a quantitative colorimetric ELISA for measuring Farletuzumab levels in plasma, serum. The assay covers a 0.31-5 μg/mL standard-curve range, detects down to 0.156 μg/mL, with typical spike recovery of 80-120%, supporting reproducible standard-curve quantification across experimental conditions.
Assay Type Quantitative Colorimetric ELISA
Sample Type Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Plate Format 96-well (96T)
Options selector
Catalog no. Size
DB825018-96T 96 T
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 96 T
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
  • Shipping: 2-8 °C
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Target Farletuzumab
Alternative names M3, MORAb-003, MORAb-003-VCP-eribulin, MORAb-202
UniProt # P15328
CAS no. 896723-44-7
Reactivity
  • Human
Applications
  • ELISA
Assay type
  • Quantitative
Sample type(s) Plasma, Serum
Sensitivity 0.156 μg/mL
Detection range 0.31-5 μg/mL
Detection method
  • Colorimetric
Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 ℃
Catalog no. (Mfr.) DB825018
Main SKU BHE21400316
Therapeutic Drug Monitoring

Assay Principle

This microplate immunoassay quantifies Farletuzumab by colorimetric detection: samples and kit standards are processed in parallel, and absorbance values are converted to concentrations through the per-plate standard curve.

Background

Farletuzumab (MORAb-003) is a humanized α-FR-targeted monoclonal antibody derived from the murine antibody, LK26 (Teng, Xie, Teng, & Lee, 2012). In preclinical studies, farletuzumab elicited robust antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, thus inhibiting the growth of human ovarian tumor xenografts (Teng et al., 2012). Farletuzumab combined with carboplatin and taxane may enhance the response rate and duration of response in patients with platinum-sensitive ovarian cancer with first relapse after remission duration of 6–18 months (Konner et al., 2010). Based on these encouraging findings, a Phase III study was undertaken in patients with platinum-sensitive recurrent ovarian cancer (Walters et al., 2013). The FAR131 trial did not prove efficacy for patients with platinum-sensitive ovarian cancer (PSOC, defined as a PFI of ≥ 6 months), in terms of the primary endpoint of PFS. Aside from Farletuzumab, other antibodies have been developed to target FR, and tested clinically. Similar to studies exploiting Vintafolide, a Phase III, open-label, randomized study (ClinicalTrials.gov Identifier: NCT02631876) was designed to compare the safety and efficacy of Mirvetuximab soravtansine, also known as IMGN853, an α-FR-targeting antibody-drug conjugate, to that of selected single-agent chemotherapies in women with platinum-resistant α-FR-positive advanced EOC, and other pelvic cancers. The antibody serves to specifically target the highly potent microtubule inhibitor maytansinoid DM4 to the α-FR-positive cancer cells. In addition, vaccines against FR have been produced and evaluated, such as the folate-binding protein vaccines E39 and J65 involved in the Phase Ib trial (ClinicalTrials.gov Identifier: NCT02019524) for patients with breast or ovarian cancer diagnosis who have been treated and are without evidence of disease. A Phase II clinical trial (NCT02764333) is testing on patients with Pt-resistant ovarian cancer the safety and effectiveness of two investigational drugs, TPIV200/huFR-1 (also called TPIV200), a vaccine consisting of proteins from α-FR mixed with GM-CSF, and durvalumab (MEDI4736).

Specifications

Assay Type Quantitative Colorimetric ELISA
Detection Method Colorimetric
Plate Format 96-well (96T)
Sample Types Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Recovery 80-120%
Stability & Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 °C
CAS Number 896723-44-7
UniProt P15328
Alternative Names M3, MORAb-003, MORAb-003-VCP-eribulin, MORAb-202

Performance Data

Performance is defined by a quantitative range of 0.31-5 μg/mL, an analytical sensitivity of 0.156 μg/mL, typical spike recovery of 80-120%. For best precision, target the central portion of the curve and confirm matrix behavior with spike-recovery and dilution-linearity checks before routine runs.

Target Notes

The target is also referenced in the literature as M3, MORAb-003, MORAb-003-VCP-eribulin. Curated target information is available under UniProt accession P15328. The corresponding compound is registered under CAS 896723-44-7.

Common Research Applications

  • Pharmacokinetic profiling of the drug in preclinical and translational research models
  • Bioanalytical method development, bridging, and comparability studies
  • Stability and formulation studies requiring reproducible concentration readouts

Safety & Handling

For Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.

Q.Which sample types are compatible with this kit?
A.The kit is validated for Plasma, Serum. For other matrices, evaluate dilution linearity and spike recovery before routine use.
Q.What is the detection limit?
A.The analytical sensitivity is 0.156 μg/mL. Samples near the detection limit should be run with replicates for reliable interpretation.
Q.What is the quantitative range?
A.The standard curve covers 0.31-5 μg/mL. Dilute concentrated samples so readings fall within this range.
Q.How should the kit be stored?
A.The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Q.How is the kit shipped?
A.The kit ships at 2-8 °C. Refrigerate upon receipt and follow the datasheet for component-level storage.
Q.Is this kit for diagnostic use?
A.No. This product is For Research Use Only (RUO) and is not intended for diagnostic or therapeutic procedures.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Matches this product
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today